BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 11095247)

  • 41. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain.
    Xing Z; Chen HC; Nowlen JK; Taylor SJ; Shalloway D; Guan JL
    Mol Biol Cell; 1994 Apr; 5(4):413-21. PubMed ID: 8054685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS.
    Maru Y; Peters KL; Afar DE; Shibuya M; Witte ON; Smithgall TE
    Mol Cell Biol; 1995 Feb; 15(2):835-42. PubMed ID: 7529874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
    Cheng HY; Schiavone AP; Smithgall TE
    Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cells.
    Mamidipudi V; Chang BY; Harte RA; Lee KC; Cartwright CA
    FEBS Lett; 2004 Jun; 567(2-3):321-6. PubMed ID: 15178345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
    Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of the Src homology domains in morphological transformation by v-src.
    Tian M; Martin GS
    Mol Biol Cell; 1997 Jul; 8(7):1183-93. PubMed ID: 9243500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between c-src tyrosine kinase activity and the control of glucose transporter gene expression.
    Matsouka PT; Flier JS
    Mol Endocrinol; 1989 Nov; 3(11):1845-51. PubMed ID: 2481817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.
    Schreiner SJ; Schiavone AP; Smithgall TE
    J Biol Chem; 2002 Nov; 277(47):45680-7. PubMed ID: 12244095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
    Briggs SD; Smithgall TE
    J Biol Chem; 1999 Sep; 274(37):26579-83. PubMed ID: 10473622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation.
    Li J; Smithgall TE
    J Biol Chem; 1998 May; 273(22):13828-34. PubMed ID: 9593727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live-cell monitoring of tyrosine phosphorylation in focal adhesions following microtubule disruption.
    Kirchner J; Kam Z; Tzur G; Bershadsky AD; Geiger B
    J Cell Sci; 2003 Mar; 116(Pt 6):975-86. PubMed ID: 12584242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal structure of the Src family tyrosine kinase Hck.
    Sicheri F; Moarefi I; Kuriyan J
    Nature; 1997 Feb; 385(6617):602-9. PubMed ID: 9024658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant transformation of a human fibroblast cell strain by transfection of a v-fes oncogene but not by transfection of a gag-human c-fes construct.
    Lin C; Wang Q; Maher VM; McCormick JJ
    Cell Growth Differ; 1994 Dec; 5(12):1381-7. PubMed ID: 7696187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.
    Briggs SD; Bryant SS; Jove R; Sanderson SD; Smithgall TE
    J Biol Chem; 1995 Jun; 270(24):14718-24. PubMed ID: 7782336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
    Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
    EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration.
    Tsubouchi A; Sakakura J; Yagi R; Mazaki Y; Schaefer E; Yano H; Sabe H
    J Cell Biol; 2002 Nov; 159(4):673-83. PubMed ID: 12446743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.
    Xu B; Miller WT
    Mol Cell Biochem; 1996 May; 158(1):57-63. PubMed ID: 8791285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of Fes kinase activity in myeloid cell growth and differentiation.
    Yates KE; Crooks GM; Gasson JC
    Stem Cells; 1996 Nov; 14(6):714-24. PubMed ID: 8948028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and structural analysis of murine c-fes cDNA clones.
    Wilks AF; Kurban RR
    Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.